Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Anders Haegerstrand
Tag: Anders Haegerstrand
Annexin confirms promising results and strengthens financial position
17 February, 2025
Annexin Pharmaceuticals: Could ANXV replace anti-VEGFs?
27 August, 2024
Annexin towards completion of phase II study and share issue
18 April, 2024
Strong start for Annexin in 2024
14 February, 2024
Annexin’s CEO: “Our biggest success in a long time”
5 September, 2023
Intense Q4 leads Annexin into interesting 2023
16 February, 2023
Annexin’s CEO: “The cancer area more than doubles the potential”
6 February, 2023
Annexin updates in conjunction with the Q3 report
10 November, 2022
Phase II focus and further potential in Annexin´s Q2
31 August, 2022
Annexin wants to treat the inconspicuous eye disease
6 July, 2022
1
2
Page 1 of 2